Your browser doesn't support javascript.
loading
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Burm, Rani; Maravelia, Panagiota; Ahlen, Gustaf; Ciesek, Sandra; Caro Perez, Noelia; Pasetto, Anna; Urban, Stephan; Van Houtte, Freya; Verhoye, Lieven; Wedemeyer, Heiner; Johansson, Magnus; Frelin, Lars; Sällberg, Matti; Meuleman, Philip.
Affiliation
  • Burm R; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Maravelia P; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Ahlen G; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Ciesek S; Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany.
  • Caro Perez N; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt am Main, Germany.
  • Pasetto A; German Center for Infection Research, DZIF, External partner site, Frankfurt am Main, Germany.
  • Urban S; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Van Houtte F; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Verhoye L; Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany.
  • Wedemeyer H; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Johansson M; Laboratory of Liver Infectious Diseases (LLID), Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Frelin L; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Sällberg M; School of Medical Sciences, Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Orebro, Sweden.
  • Meuleman P; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Gut ; 72(6): 1186-1195, 2023 06.
Article in En | MEDLINE | ID: mdl-35977815

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Superinfection / Hepatitis B, Chronic / Hepatitis B Limits: Animals / Humans Language: En Journal: Gut Year: 2023 Document type: Article Affiliation country: Belgium

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Superinfection / Hepatitis B, Chronic / Hepatitis B Limits: Animals / Humans Language: En Journal: Gut Year: 2023 Document type: Article Affiliation country: Belgium